Health & Biotech
Osteopore delivers strong sequential quarterly sales growth, expects further traction as pandemic restrictions loosen
Experts
SocPo’s Powerplays: A few healthcare gems among the carnage
Health & Biotech
Diagnostic stock Atomo soars 12pc after scoring RAT distribution rights in New Zealand
Health & Biotech
RedLeaf: Singular has a sweet slice of the global VR, AI medical imaging pie
Health & Biotech
ASX Health Stocks: Weed stock Cann Group gets licence from TGA for its cannabis facility
Health & Biotech
EZZ to focus on combating cancer-causing digestive tract bacteria
Health & Biotech
Emerald hydrogen could supercharge Pure Hydrogen
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
ASX Health Stocks: HeraMED signs major deal for pregnancy monitoring platform
Health & Biotech
TGA provisionally approves Nuvaxovid vaccine and two oral COVID-19 treatments
Health & Biotech
This new AI Covid test could pump out a diagnosis quicker than a PCR
Health & Biotech
Check Up: Immuron wins big in US and Europe on travellers’ diarrhoea drug
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.